ASX - Delayed Quote AUD

Sonic Healthcare Limited (SHL.AX)

26.60 -0.14 (-0.52%)
As of 11:18 AM GMT+10. Market Open.
Loading Chart for SHL.AX
DELL
  • Previous Close 26.74
  • Open 26.29
  • Bid 26.59 x 46100
  • Ask 26.60 x 14600
  • Day's Range 26.26 - 26.69
  • 52 Week Range 25.72 - 36.40
  • Volume 381,619
  • Avg. Volume 1,398,554
  • Market Cap (intraday) 12.779B
  • Beta (5Y Monthly) 0.49
  • PE Ratio (TTM) 24.86
  • EPS (TTM) 1.07
  • Earnings Date Feb 20, 2024
  • Forward Dividend & Yield 1.05 (3.93%)
  • Ex-Dividend Date Mar 1, 2024
  • 1y Target Est 30.94

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

www.sonichealthcare.com

41,000

Full Time Employees

June 30

Fiscal Year Ends

Recent News: SHL.AX

Performance Overview: SHL.AX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SHL.AX
15.87%
S&P/ASX 200 [XJO]
0.02%

1-Year Return

SHL.AX
22.99%
S&P/ASX 200 [XJO]
3.73%

3-Year Return

SHL.AX
19.83%
S&P/ASX 200 [XJO]
7.72%

5-Year Return

SHL.AX
19.57%
S&P/ASX 200 [XJO]
18.85%

Compare To: SHL.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SHL.AX

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    12.85B

  • Enterprise Value

    16.22B

  • Trailing P/E

    25.06

  • Forward P/E

    17.70

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.51

  • Price/Book (mrq)

    1.67

  • Enterprise Value/Revenue

    1.94

  • Enterprise Value/EBITDA

    10.49

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.02%

  • Return on Assets (ttm)

    3.83%

  • Return on Equity (ttm)

    6.90%

  • Revenue (ttm)

    8.39B

  • Net Income Avi to Common (ttm)

    504.94M

  • Diluted EPS (ttm)

    1.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    619.61M

  • Total Debt/Equity (mrq)

    50.49%

  • Levered Free Cash Flow (ttm)

    356.22M

Research Analysis: SHL.AX

Analyst Price Targets

25.95
30.94 Average
26.60 Current
34.94 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: SHL.AX

People Also Watch